Skip to main content
NCBI home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1985 Feb;61(712):133–139. doi: 10.1136/pgmj.61.712.133

The evaluation of clinical trials.

R R Jackson
PMCID: PMC2418148  PMID: 3983040

Full text

PDF
133

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altman D. G. Statistics and ethics in medical research: study design. Br Med J. 1980 Nov 8;281(6250):1267–1269. doi: 10.1136/bmj.281.6250.1267. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Cornfield J. Recent methodological contributions to clinical trials. Am J Epidemiol. 1976 Oct;104(4):408–421. doi: 10.1093/oxfordjournals.aje.a112313. [DOI] [PubMed] [Google Scholar]
  3. Cranberg L. For debate: Do retrospective controls make clinical trials "inherently fallacious?". Br Med J. 1979 Nov 17;2(6200):1265–1266. doi: 10.1136/bmj.2.6200.1265. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FIX E., NEYMAN J. A simple stochastic model of recovery, relapse, death and loss of patients. Hum Biol. 1951 Sep;23(3):205–241. [PubMed] [Google Scholar]
  5. Freiman J. A., Chalmers T. C., Smith H., Jr, Kuebler R. R. The importance of beta, the type II error and sample size in the design and interpretation of the randomized control trial. Survey of 71 "negative" trials. N Engl J Med. 1978 Sep 28;299(13):690–694. doi: 10.1056/NEJM197809282991304. [DOI] [PubMed] [Google Scholar]
  6. GEHAN E. A. A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES. Biometrika. 1965 Jun;52:203–223. [PubMed] [Google Scholar]
  7. Gehan E. A., Freireich E. J. Non-randomized controls in cancer clinical trials. N Engl J Med. 1974 Jan 24;290(4):198–203. doi: 10.1056/NEJM197401242900405. [DOI] [PubMed] [Google Scholar]
  8. Goldie J. H., Coldman A. J. A mathematic model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep. 1979 Nov-Dec;63(11-12):1727–1733. [PubMed] [Google Scholar]
  9. Goldie J. H., Coldman A. J., Gudauskas G. A. Rationale for the use of alternating non-cross-resistant chemotherapy. Cancer Treat Rep. 1982 Mar;66(3):439–449. [PubMed] [Google Scholar]
  10. Gore S. M. Statistics in question. Assessing methods--many variables. Br Med J (Clin Res Ed) 1981 Oct 3;283(6296):901–905. doi: 10.1136/bmj.283.6296.901. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gregory W., Bell R., Jackson R. R. An automated clinical research and data analysis system. Comput Biomed Res. 1981 Oct;14(5):472–481. doi: 10.1016/0010-4809(81)90023-9. [DOI] [PubMed] [Google Scholar]
  12. HILL A. B. The clinical trial. N Engl J Med. 1952 Jul 24;247(4):113–119. doi: 10.1056/NEJM195207242470401. [DOI] [PubMed] [Google Scholar]
  13. Mould R. F. Clinical trial design in cancer. Clin Radiol. 1979 Jul;30(4):371–381. doi: 10.1016/s0009-9260(79)80211-1. [DOI] [PubMed] [Google Scholar]
  14. Peto R., Pike M. C., Armitage P., Breslow N. E., Cox D. R., Howard S. V., Mantel N., McPherson K., Peto J., Smith P. G. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design. Br J Cancer. 1976 Dec;34(6):585–612. doi: 10.1038/bjc.1976.220. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tautu P. Mathematical models in oncology: a bird's-eye view. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1978;91(3):223–235. doi: 10.1007/BF00312285. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES